Hemoglobin H-Constant Spring Disease Who Survives Longer Than Eight Decades: A Case Report
Main Article Content
Abstract
Hemoglobin H-Constant Spring disease is a genetically transmitted microcytic anemia. It is one of alpha thalassemias that is usually characterized by the moderate degree of anemia. Although it is highly prevalentin Thailand, it has never been found in the patient of more than 8 decades of age as in our patient. He was an 83-year-old Thaimarried man who was referred to a hematologist because of chronic anemia. The physical examination revealed only pallor, no jaundice, and no hepatosplenomegaly. The blood tests showed: Hb 6.5 g%, Hct 22.0 %, MCV 71.0 fL, MCH 21.0 pg, normal WBC and platelet counts, mild poikilocytosis, microcytosis, and hypochromia, and the presence of polychromasia. The Hb electrophoresis using capillary zone electrophoresis method (Sebia®): Hb CSA2 AH, Hb H11.3 % and Hb Constant Spring 3.7 %, serum ferritin 2,446.64 ng/mL. The direct antiglobulin test was negative. The definite diagnosis was Hb H-Constant Spring with secondary hemosiderosis. He refused to be transfused and he had never been transfused for life because of lack of anemic symptom at all. Only genetic counseling, folic acidanddeferiprone were offered to him. Many factors were proposed to contribute the long lasting sick patient the longevity more than 8 decades that was more than the male life expectancy of 70.96 years in Thailand, including the short stature with quite low BMI, serum ferritin less than 2,500 ng/mL, living in the country, no smoking, and working hard in the paddy field for life.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Sutcharitchan P, Wang W, Settapiboon1 R, Amornsiriwat S, Tan ASC, Chong SS. Hemoglobin H disease classification by isoelectric focusing: molecular verification of 110 cases from Thailand. Clin Chem 2005; 51: 641-4
Singer ST, Kim HY, Olivieri NF, Kwiatkowski JL, Coates TD, Carson S, et al. Hemoglobin H-constant spring in North America: An alpha thalassemia with frequent complications. Am J Hematol 2009; 84: 759-61.
Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bull World Health Organ 1995; 73: 375-86.0
Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003; 101: 791-800.
Life expectancy of Thailand goes up to 74.25 years. Available at: http://countryeconomy. com/demography/life-expectancy/thailand
Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusionaliron overload. Blood 2003; 102: 17-24.
Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y AcadSci 2005; 1054: 40-7.
Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients wit
thalassemia major in Greece. Ann N Y AcadSci 2005; 1054: 445-50.
Modell B, Khan M, Darlison M. Survival in betathalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000; 355: 2051-2.
Crush P. 10 surprising factors which could affect your life expectancy. Available at: www. workplacefocus.co.uk
Height Chart of Men and Women in Different Countries. Available at: http://www.disabled-world.com/artman/publish/height-chart.shtml
Kondo K, Iwamoto T, Hirano R. Factors affecting longevity. Southeast Asian J Trop Med Public Health 1997; 28 Suppl 2: 88-93.